| Entry |
|
|---|
| Name |
Lascufloxacin hydrochloride (JAN);
Lasvic (TN)
|
|---|
| Formula |
C21H24F3N3O4. HCl
|
|---|
| Exact mass |
475.1486
|
|---|
| Mol weight |
475.8891
|
|---|
| Structure |
|
|---|
| Class |
|
|---|
| Remark |
| Therapeutic category: | 6241 |
|
|---|
| Efficacy |
Antibacterial |
|---|
| Comment |
Fluoroquinolones
|
|---|
| Interaction |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
624 Synthetic antibacterials
6241 Pyridonecarboxylic acids
D10772 Lascufloxacin hydrochloride (JAN)
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10772
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10772
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 32
1 N1y N 16.7442 -16.8960
2 C8y C 17.9409 -16.1921
3 O2a O 19.1376 -18.3742
4 C1b C 21.5309 -18.3742
5 C8y C 19.1376 -16.9664
6 C8y C 17.9409 -14.7842
7 C8x C 19.1376 -14.0803
8 N4y N 21.5309 -16.9664
9 C8y C 20.3342 -16.2625
10 C8y C 20.3342 -14.8546
11 C8y C 21.5309 -14.1507
12 C8y C 22.7979 -14.8546
13 C8x C 22.7979 -16.2625
14 C6a C 23.9946 -14.1507
15 O6a O 23.9946 -12.8133
16 O6a O 25.1913 -14.8546
17 O5x O 21.5309 -12.8133
18 X F 16.6738 -14.0803
19 C1a C 17.9409 -19.0781
20 C1b C 22.7275 -19.0781
21 X F 23.9242 -18.3742
22 C1x C 15.6180 -16.0513
23 C1y C 14.4917 -16.8960
24 C1y C 14.9141 -18.2334
25 C1x C 16.3219 -18.2334
26 X F 14.1397 -19.4301
27 C1b C 13.2950 -16.1921
28 N1b N 12.0984 -16.8960
29 C1y C 10.9017 -16.1921
30 C1x C 9.4939 -16.1921
31 C1x C 10.1978 -14.9954
32 X Cl 27.7254 -19.5005
BOND 34
1 2 6 2
2 6 7 1
3 7 10 2
4 3 5 1
5 8 4 1
6 8 9 1
7 9 10 1
8 10 11 1
9 11 12 1
10 12 13 2
11 13 8 1
12 12 14 1
13 2 1 1
14 14 15 2
15 14 16 1
16 11 17 2
17 9 5 2
18 6 18 1
19 5 2 1
20 3 19 1
21 4 20 1
22 20 21 1
23 1 22 1
24 22 23 1
25 23 24 1
26 24 25 1
27 1 25 1
28 24 26 1 #Up
29 23 27 1 #Up
30 27 28 1
31 28 29 1
32 30 29 1
33 31 30 1
34 29 31 1
|
|---|
